Moderna Inc at JPMorgan Healthcare Conference Transcript
Great. Welcome, everyone. Good afternoon. Good afternoon. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing the 42nd Annual Healthcare Conference today with Moderna.
I'm going to pass it over to the company's CFO, Jamey Mock, for a presentation, and then we're going to go into Q&A. If you have a question, you can submit them to the portal, or I think someone will bring you a mic. But with that, let me pass it over to Jamey.
Terrific. Well, thank you, Jess, and thanks to the JPMorgan team for another terrific conference. Good afternoon, and it's a pleasure to be here with you today. On behalf of the entire global Moderna team, we thank you for your interest. Thank you for being here in person or live via our webcast.
So before I begin, I will make -- in this presentation, we'll make forward-looking statements. Those are to the best of our estimates right now and that's subject to risks and uncertainties.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |